Home » Topics » BioWorld Science

BioWorld Science
RSS

Exscientia announces collaboration with Rallybio for development of rare disease therapeutics

July 25, 2019

CR3 is a potential therapeutic target for treating Neisseria gonorrhoeae infection

July 25, 2019

HitGen describes stimulator of interferon genes protein agonists

July 25, 2019

Guangzhou Henovcom Bioscience patents MAP3K5 inhibitors

July 25, 2019

New CSF-1 receptor inhibitors described by Medshine Discovery

July 25, 2019

Wuxi Advant Biotechnology identifies NUDT1 inhibitors

July 25, 2019

King Saud University discovers new calcium channel blockers

July 25, 2019

Brain drain may hold key to treating neurodegenerative diseases

July 25, 2019

Orion's OB-002 shown to be more potent than maraviroc in a model of HIV infection

July 25, 2019

Novel p53 gene therapy increases efficacy of cabazitaxel in prostate carcinoma models

July 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...